PIH1D1 and breast cancer: Of these, we focused on amphiregulin, because its probe signal was markedly up-regulated both in RPAP3 and PIH1D1 siRNA-treated cells; moreover, amphiregulin has been reported to have high levels of expression in hormone therapy-resistant breast cancer cells [4], [26], [27].